Capability measurement of size-exclusion chromatography with a light-scattering detection method in a stability study of bevacizumab using the process capability indices

Journal of Chromatography A

Volumn 1353, Issue , 2014, Pages 89-98

  Oliva, Alexis ^a   Llabrés, Matías ^a   Fariña, José B ^a  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Bevacizumab; Capability indices; Control chart; Light scattering; SEC; Stability

Indexed keywords

CONVERGENCE OF NUMERICAL METHODS; LIGHT SCATTERING; PROCESS CONTROL; REFRACTIVE INDEX;

BEVACIZUMAB; CAPABILITY INDICES; CONTROL CHARTS; LIGHT-SCATTERING DETECTION; MEAN AND STANDARD DEVIATIONS; PHARMACEUTICAL PREPARATIONS; PROCESS CAPABILITY INDICES; SEC;

SIZE EXCLUSION CHROMATOGRAPHY;

BEVACIZUMAB; BOVINE SERUM ALBUMIN; MONOCLONAL ANTIBODY;

ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG QUALITY; DRUG STABILITY; DRUG STORAGE; GEL PERMEATION CHROMATOGRAPHY; LIGHT SCATTERING; MEASUREMENT ACCURACY; MECHANICAL STRESS; PRIORITY JOURNAL; QUALITY CONTROL; REFRACTION INDEX; TEMPERATURE STRESS; ANIMAL; BAYES THEOREM; BOVINAE; GEL CHROMATOGRAPHY; LIGHT; MOLECULAR WEIGHT; PROCEDURES; REFRACTOMETRY;

BOVINAE;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; BAYES THEOREM; CATTLE; CHROMATOGRAPHY, GEL; LIGHT; MOLECULAR WEIGHT; REFRACTOMETRY; SERUM ALBUMIN, BOVINE;

EID: 84903129243     PISSN: 00219673     EISSN: 18733778     Source Type: Journal    
DOI: 10.1016/j.chroma.2014.04.027     Document Type: Article

References (42)

1. Kükrer B., Filipe V., van Dujn E., Kasper P.T., Vreeken R.J., Heck A.J.R., Jiskoot W. Pharm. Res. 2010, 27:2197.
2. Presta L.G., Chen H., O'Connor S.J., Chisholm V., Meng Y.G., Krummen L., Winkler M., Ferrara N. Cancer Res. 1997, 57:4593.
3. Grisanti S., Biester P., Peters S., Tatar O., Ziemssen F., Bartz-Schmidt K.U. Am. J. Ophthalmol. 2006, 142:158.
4. Swethat V., Jeganathan E., Verma N. Curr. Opin. Ophthalmol. 2009, 20:223.
5. Crommelin D.J.A. Formulation of Biotech Products. Including Biopharmaceuticals Considerations in Pharmaceutical Biotechnology 2002, Taylor and Francis, London. D.J.A. Crommelin, R.D. Sindelar (Eds.).
6. Morris A.M., Watzky M.A., Finke R.G. Biochim. Biophys. Acta 2009, 1794:375.
7. International Conference on Harmonization (ICH) of Technical Requirements for the Registration of Pharmaceutical for Human Use, Validation of Analytical Procedures: Text and Methodology, ICH-Q2 (R1), November 2005.
8. FDA Guidance for Industry, Bioanalytical Methods Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CEDER), May 2001.
9. Wen J., Arakawa T., Philo J.S. Anal. Biochem. 1996, 240:155.
10. Arakawa T., Wen J. Anal. Biochem. 2001, 299:158.
11. Folta-Stogniew E., Williams K.R. J. Biomol. Tech. 1999, 10:51.
12. Oliva A., Llabrés M., Fariña J.B. J. Pharm. Biomed. Anal. 2001, 25:833.
13. Kendrick B.S., Kerwin B.A., Chang B.S., Philo J.S. Anal. Biochem. 2001, 299:136.
14. Oliva A., Fariña J.B., Llabrés M. Curr. Pharm. Anal. 2007, 3:230.
15. Wyatt P.J. Anal. Chim. Acta 1993, 272:1.
16. Dollinger G., Cunico B., Kunitani M., Johnson D., Jones R. J. Chromatogr. 1992, 592:215.
17. Oliva A., Fariña J.B., Llabrés M. Anal. Chim. Acta 2004, 512:103.
18. Bouabidi A., Ziemons E., Marini R., Hubert C., Talbi M., Bouklouze A., Bourichi H., El Karbane M., Boulanger B., Hubert Ph., Rozet E. Anal. Chim. Acta 2012, 714:47.
19. Dejaegher B., Jimidar M., De Smet M., Cockaerts P., Smeyers-Verbeke J., Van der Heyden Y. J. Pharm. Biomed. Anal. 2006, 42:155.
20. Kamberi M., García H., Ferer D.P., Rapoza R.J. Eur. J. Pharm. Sci. 2011, 42:230.
21. Raske C.S., Bennett T.S., Goodberlet S.A. Anal. Chem. 2010, 82:5932.
22. Pearn W.L., Shu M.H. Int. J. Prod. Res. 2003, 41:3581.
23. Box G.P., Tiao G. Bayesina Inference in Statistical Analysis 1973, Addison-Wesley Publishing Company Inc., California, USA.
24. Chan L.K., Cheng S.W., Spiring F.A. J. Qual. Technol. 1988, 20:162.
25. Pearn W.L., Kotz S., Johnson N.L. J. Qual. Technol. 1992, 24:216.
26. Wu C.W., Pearn W.L., Kotz S. Int. J. Prod. Econ. 2009, 117:338.
27. Kotz S., Lovelace C. Process Capability Indices in Theory & Practice 1998, Arnold, London, UK.
28. Kotz S., Johnson N.L. Process Capability Indices 1993, Chapman and Hall, London.
29. Kotz S., Johnson N.L. J. Qual. Technol. 2002, 34:1.
30. Spiring F., Leung B., Cheng S., Yeung A. Qual. Reliab. Eng. Int. 2003, 19:445.
31. Montgomery D.C. Introduction to Statistical Quality Control 2008, Wiley, New York. 6th ed.
32. Boyles R.A. J. Qual. Technol. 1991, 23:17.
33. Efron B., Tibshirani R.J. Stat. Sci. 1986, 1:54.
34. International Conference on Harmonization, Guideline for Industry, Stability Testing of New Drug Substances and Products, ICH-Q1A(R1), August 2001.
35. Reynolds M.R., Stoumbos Z.G. J. Qual. Technol. 2001, 33:181.
36. Batson R.G., Jeong Y., Fonseca D.J., Ray P.S. Qual. Reliab. Eng. Int. 2006, 22:733.
37. English J.R., Taylor G.D. Int. J. Prod. Res. 1993, 31:1621.
38. ExPASy Bioinformatics Resource Portal,. http://www.expasy.org/.
39. Mathew T., Sebastian G., Karian K.M. Qual. Reliab. Eng. Int. 2007, 23:471.
40. Pearn W.L., Shu M.H. Int. J. Adv. Manuf. Technol. 2004, 23:116.
41. Pearn W.L., Shu M.H., Shu B.M. J. Appl. Stat. 2005, 32:1003.
42. Shu B.M., Shu M.H., Pearn W.L. Qual. Reliab. Eng. Int. 2007, 23:597.